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Enterohemorrhagic Escherichia coli O157:H7 is an important intestinal pathogen of humans with a main
reservoir of domesticated ruminants, particularly cattle. It is anticipated that the risk of human infection can
be reduced by controlling the organism within its reservoir hosts. Several options for the control of E. coli
O157:H7 in cattle have been proposed, but none have been demonstrated to be successful in the field. Here we
describe a novel experimental method, based on the terminal-rectum-restricted colonization described previ-
ously, to eliminate fecal carriage of E. coli O157:H7. In experimentally challenged calves, direct application to
the rectal mucosa of either of two therapeutic agents, polymyxin B or chlorhexidine, greatly reduced bacterial
shedding levels in the immediate posttreatment period. The most efficacious therapeutic agent, chlorhexidine,
was compared in orally and rectally challenged calves. The treatment eliminated high-level shedding and
reduced low-level shedding by killing bacteria at the terminal rectum. A rapid-detection system based on the
ability to identify E. coli O157:H7 from swabs of the rectal mucosa was also assessed. This test was sufficiently
sensitive to identify high-level bacterial carriage. Thus, a combination of the detection method and treatment
regimens could be used in the field to eliminate high-level fecal excretion of E. coliO157:H7, so greatly reducing
its prevalence within this host and the risk of human infection.
Enterohemorrhagic Escherichia coli (EHEC) has emerged in
developed countries over the past 20 years as an important
cause of human intestinal disease. In addition to bloody diar-
rhea, intestinal infection can lead to potentially fatal systemic
sequelae resulting from the activity of Shiga toxins. The ma-
jority of these infections in the United States, Canada, United
Kingdom, and Japan are caused by E. coli O157:H7 (23). This
serotype has been frequently isolated from cattle feces, and
most human E. coli O157:H7 infections originate, either di-
rectly or indirectly, from this source (2, 3). Control measures
have sought to minimize the transmission of E. coli O157:H7
and other EHEC strains from cattle to humans via the food
chain. Among the preslaughter control strategies, the most
effective would be those that reduce fecal shedding from food-
producing animals (18). For example, a reduction in the inci-
dence of human infections in the United States coincided with
improved screening and removal of E. coli O157:H7-positive
meat in beef-processing plants following a Food Safety and
Inspection Service notice in 2002 (9). However, routes of trans-
mission other than the food chain, such as infection through
drinking water (20) or direct contact with animal feces (10), are
significant in certain parts of the world. Therefore, to reduce
the risk of E. coli O157:H7 infection for humans requires
control within the bovine population.
To our knowledge, there is no method currently being ap-
plied to control the colonization by this microorganism in food-
producing animals. However, several methods have been
tested experimentally and these have been thoroughly re-
viewed (8, 30). Vaccination is potentially the most effective and
economically viable option, and several candidate vaccines
have been examined (14, 19, 34). Though a vaccine based on
secreted proteins showed experimental promise (32), at field
scale this did not perform satisfactorily (25). Other vaccines
are being developed, but the possibility exists that none will be
sufficiently protective to substantially reduce prevalence levels.
Several groups have observed an effect on fecal shedding (de-
termined either by prevalence, duration of shedding, or fecal
concentration) from various biological controls (4, 5, 29, 31, 33,
35). Dietary manipulations have also been reported to alter
fecal shedding of E. coli O157:H7 in cattle, but data from
different studies are conflicting (17, 27). Chemical compounds
with antimicrobial activity, esculin (15) and sodium chlorate (7),
have both been shown to reduce prevalence experimentally, but
the latter has not been approved for use in food-producing ani-
mals due to potential mammalian toxicity. More-conventional
antimicrobials, such as neomycin and oxytetracycline, had little
effect on shedding levels in calves in one study (1), but in another
study neomycin was shown to reduce shedding in calves (16).
However, continuous use of antimicrobials to treat E. coli
O157:H7 has been traditionally seen as unacceptable through
fears of selecting for bacterial resistance.
Since the maintenance of E. coli O157:H7 within a cattle
population can be dependent upon a small proportion of cattle
that are shedding high levels of the organism in feces (22), a
* Corresponding author. Mailing address: Animal Health Group,
Scottish Agricultural College, West Mains Road, Edinburgh EH9 3JG,
United Kingdom. Phone: 44 131 5353150. Fax: 44 131 5353121. E-mail:
chris.low@sac.ac.uk.
 Published ahead of print on 12 January 2007.
1493
control strategy that successfully targets this minority of posi-
tive animals should have a major impact on E. coli O157:H7
prevalence. Colonization of the terminal rectum (TR) is re-
quired for this high-level fecal shedding (21), and targeting of
treatments to the TR (24) provides an excellent opportunity
for a control method. The accessibility of the site means that
antimicrobial agents can be applied directly to the TRs of
food-producing animals in a single application. By the same
principle, the effect of applying multiple doses of E. coli
O157:H7 lytic bacteriophages to the TRs of colonized cattle
has been recently assessed (29) and reduced but did not elim-
inate bacterial shedding. In this study, two compounds, poly-
myxin B and chlorhexidine, were assessed for the ability to
reduce or eliminate E. coli O157:H7 from experimentally chal-
lenged calves by administration directly to the rectal mucosa. It
has shown that a proportion of orally challenged calves have
low levels of E. coli O157:H7 originating from regions other
than the TR, as demonstrated by postmortem sampling of
intestinal contents within this and previous studies (6, 11, 24).
Our experimental design therefore involved a comparison of
treatment efficacy in both rectally and orally challenged calves
in order to assess the impact on fecal shedding of non-TR sites
of colonization. An initial experiment (experiment 1) involved
a total of 54 weaned calves in three batches of 18 that were
challenged with a nalidixic acid-resistant, Shiga toxin-negative
E. coli O157:H7 strain (ZAP 198) (24). The initial objective
was to compare E. coli O157:H7 shedding following rectal
challenge to the established oral challenge route (24), as it was
important to demonstrate that the two challenge routes cre-
ated qualitatively and quantitatively similar patterns of coloni-
zation at the TR. Rectal challenge would then permit an as-
sessment of the efficacy of subsequent treatment methods in
the absence of bacteria originating from nonrectal sites.
The objective of experiment 2 was to assess the impact of
two agents applied to the TR mucosa on E. coli O157:H7
shedding. In experiment 2, a total of 53 calves in six batches
were successfully colonized (defined by fecal E. coli O157:H7
concentrations of greater than 103 CFU/g immediately prior to
treatment). Initially, both the chlorhexidine and polymyxin
protocols were highly successful in rectally challenged calves
but the chlorhexidine treatment was selected for more exten-
sive assessment.
Detection of rectally colonized E. coli O157:H7 by rectal
swabbing of colonized cattle is a highly sensitive means of
identifying positive animals when combined with enrichment
culture (13, 26). An additional objective within this study was
to combine rectal swabbing with an immunochemical test of
sufficient sensitivity to create a rapid field method to detect
high-level bacterial shedding. Such a procedure could offer
many advantages when used in conjunction with the aforemen-
tioned treatment regimen.
MATERIALS AND METHODS
Animals and experimental challenge. Experimental calf challenges were per-
formed at Moredun Research Institute (MRI) in containment level 2 housing
facilities authorized by Home Office license number 60/3179. Ethical consent was
obtained from the MRI Animal Experiments Committee. Calves were reared
conventionally on the same farm of origin until at least 2 weeks postweaning and
transported to MRI, where they were acclimatized for 1 week prior to challenge.
Calves were tethered in individual pens separated by solid walls. They were fed
twice daily on QRD pellets (BOCM Pauls, Renfrew, United Kingdom) and had
ad libitum access to hay and water. Prior to challenge, fecal samples from each
calf were confirmed to be negative for E. coli O157 by overnight enrichment
culture in tryptic soya broth (Oxoid) containing 20 mg/liter novobiocin, followed
by immunomagnetic separation with anti-O157 immunoglobulin-coated para-
magnetic beads (IDG, United Kingdom) and culture on CT-SMAC plates
(cefixime-tellurite sorbitol MacConkey; Oxoid). At the time of challenge, the
mean calf ages were 114 days (experiment 1, orally challenged), 115 days (ex-
periment 1, rectally challenged), 80 days (experiment 2, orally challenged), and
71 days (experiment 2, rectally challenged).
Bacterial challenge and enumeration. The challenge bacteria (nalidixic acid-
resistant E. coli O157:H7 Walla 3) were cultured overnight in L broth (Invitro-
gen) at 37°C with aeration. Each oral inoculum was created by adding 1 ml of
undiluted culture to 20 ml of phosphate-buffered saline (PBS), resulting in
approximately 109 CFU per dose. The oral inocula were administered to the
calves via a stomach tube and washed down with 500 ml of sterile PBS. Rectal
challenge was performed by smearing a large cotton swab (150-mm Jumbo
cotton swab; Fisher Scientific) saturated with approximately 1 ml of an undiluted
overnight bacterial culture (109 CFU/ml) over the rectal mucosa, a method
similar to that described by Sheng et al. (28).
Feces were sampled on a daily basis and separated into surface and core
components as previously described (24). There were some missing data; one calf
died of unrelated causes, and three calves in one group became colonized with
a nalidixic acid-resistant, sorbitol-fermenting E. coli strain that obscured the
selective media used for enumeration. Stools were graded according to the ease
with which the surface and core components were separated (A, separation likely
to be poor due to feces being dry and pelleted; B, separation likely to be good;
C, separation likely to be poor due to feces being too soft; D, separation
impossible due to feces being liquid). Samples too liquid to be separated were
processed as “whole feces.” Ten-gram quantities of feces were homogenized in
90 ml of sterile PBS and where appropriate were serially diluted in 10-fold steps
in PBS. One hundred microliters of each dilution was spread onto sorbitol
MacConkey agar plates containing 15 g ml1 nalidixic acid (N-SMAC; Oxoid).
All inoculated media were incubated overnight at 37°C. Non-sorbitol-fermenting
colonies were counted, and a colony from each sample was tested for O157
lipopolysaccharide (LPS) with a latex agglutination test kit (Oxoid). The con-
centration of E. coli O157:H7 in log10 CFU per gram was calculated. When
performed, enrichment cultures consisted of 1 ml of an undiluted fecal suspen-
sion added to 9 ml of L broth containing 15 g ml1 nalidixic acid. Following
incubation at 37°C for 24 h, the enrichment cultures were streaked onto N-
SMAC plates and these were incubated overnight at 37°C.
Postmortem sampling. Postmortem sampling was performed on calves shed-
ding E. coli O157:H7 beyond day 14 postchallenge in experiment 1 to confirm the
TR-restricted colonization of rectally challenged calves and provide information
on the possible degree of non-TR colonization of orally challenged calves. A full
description of the methods and results of the postmortem sampling will be
submitted for publication elsewhere. Essentially, 10-g samples of gut contents
were obtained and E. coli O157:H7 bacteria were enumerated as described for
feces above. For this paper, results from the large intestinal contents have been
pooled. The proximal colon concentration was the mean of contents from three
sites: the apex of the cecum, the ileocecocolic valve, and the site just proximal to
the narrowing where the proximal colon becomes the spiral colon. The mid/
distal-colon concentration was the mean of the contents from the spiral colon
(point of inflection) and the distal colon (midway between the spiral colon and
rectum).
Application of therapeutic agents to the TR. In experiment 2, application of
therapeutic agents was performed at 7 days postchallenge. This timing band was
selected, on the basis of results of experiment 1 and previous experience with this
model, to allow sufficient time for establishment of colonization and before the
point at which levels of E. coli O157:H7 shedding were expected to fall. Two
treatment preparations were developed. One preparation included polymyxin B
sulfate at a concentration of 2 mg/ml with sodium alginate at 10 mg/ml. This was
applied via a syringe to the rectal mucosa in a volume of 100 ml. The second
preparation contained chlorhexidine gluconate at a concentration of 2% (wt/vol)
in a total volume of 500 ml. The choices of therapeutic agents were based on
minimal gut absorption, low host toxicity, bactericidal efficacy, and a low risk of
generating bacterial resistance. Alginate was used in the polymyxin preparation
to increase the time of contact with the mucosal surface. This was not used for
the chlorhexidine preparation, as a larger volume was applied. Therapeutic
concentrations were based upon in vitro determination of the concentration and
time required to achieve 100% killing of the challenge strain (data not shown).
Swab recovery and E. coli O157 detection. The rectal mucosas of calves to be
treated with therapeutic agents in experiment 2 were swabbed with large cotton
swabs that were then vortexed in 5 ml of PBS. The presence of E. coli O157 was
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detected by immersing an O157 Coli-Strip (Coris BioConcept, Belgium) in 0.25
ml of swab suspension and reading the result 15 min later. The strength of the
band, if positive, was subjectively categorized as weak, moderate, or strong. The
concentration of E. coli O157:H7 in the swab suspension was determined by
plating a serial dilution onto N-SMAC plates as described for fecal bacterial
enumeration. Samples obtained in the latter part of the experiment were addi-
tionally processed if the initial test result was negative; the swab suspension was
filtered through a 3-m-pore-size glass fiber filter (type A/D; Pall) and centri-
fuged (1,500  g for 10 min), and the deposit was resuspended in 100 l of
sample diluent. A second O157 Coli-Strip was then immersed in the suspension
and read 15 min later.
Quantification of serum anti-O157 LPS IgG. Serum samples of experiment 1
calves were collected prior to challenge and at postmortem. Purified O157 (List
Biological Laboratories) was conjugated to polymyxin B as previously described
(12) and used as a coating antigen for an indirect enzyme-linked immunosorbent
assay. Microtiter plates (Immulon 2 HB; Thermo Electron) were coated at the
optimum coating concentration, determined to be 1 g per well in 100 l of
carbonate buffer, and incubated overnight at 4°C. Twofold dilution series of test
and standard sera from 1 in 12.5 to 12,800 were applied to the coated plates,
which were then incubated for 1 h. Pre- and postchallenge serum samples from
the same calves were always tested on the same plate. After washing, the sec-
ondary antibody (sheep anti-bovine immunoglobulin G [IgG] conjugated with
horseradish peroxidase; Serotec) diluted 1 in 800 was added for 1 h of incubation
and then the plates were washed and developed with substrate (Sigma-Fast
OPD; Sigma-Aldrich). Plates were read in a Dynex Revelation 3.04 enzyme-
linked immunosorbent assay plate reader at 492 nm. Endpoint titers were de-
termined, and the fold increase in the postcolonization samples relative to the
prechallenge serum titer was calculated for each calf.
Data analysis. Unless otherwise stated, bacterial counts are expressed as the
log10 (count plus one) to permit samples with zero plate counts to be expressed
as zero. However, it is possible that a sample expressed as zero may have
contained bacteria at levels below the limit of detection, in theory, log10 1.5. A
repeated-measures model was fitted to the log counts for the surface samples for
the first 14 days postchallenge; after day 14, high-shedding calves were selectively
culled. Calf group and route of challenge were included as factors in the model.
Because the data set contained some missing observations, the correlation be-
tween observations on the same animal was modeled with a power model.
Additional statistics were used to summarize the colonization ability and shed-
ding patterns of the challenge strain administered by the rectal and oral routes.
These statistics were calculated from E. coli O157:H7 counts from surface feces
(or whole feces when separation was not possible). The area under the curve
(AUC) for shedding for the first 14 days postchallenge was calculated by the
trapezoidal method. Uptake was the proportion of challenged calves that became
colonized initially (AUC, 10). The peak level was the highest E. coli O157:H7
concentration observed within the shedding period. Persistence was the propor-
tion of calves that were initially colonized with E. coli O157:H7 still detectable by
direct plating at day 14 postchallenge. The distribution of anti-O157 LPS IgG
serum titers was positively skewed, and the results are expressed as log2 relative
titers. Pre- and postcolonization titers were compared with a one-sample t test.
The graphs in Fig. 1 feature mean surface and core fecal E. coli O157:H7
concentrations calculated from day 1 postchallenge by using all samples where
separation was possible (grades A, B, and C) in all animals with confirmed
uptake (AUC, 10).
In experiment 2, calves with surface fecal concentrations of at least 103 CFU/g
on the day of treatment were included in the analyses of the treatment effect. In
order to estimate the changes in fecal concentration in response to treatment, a
general linear mixed model was fitted to the change in the number of CFU per
gram between the immediate pretreatment and 1 day posttreatment (PT) sam-
ples. The type of intervention and route of challenge were included as fixed
effects, and calf batch was included as a random effect. Approximate 95%
confidence intervals for the mean change were calculated as the mean plus or
minus two times the appropriate standard error. Further analysis was performed
on the bacterial counts for several time points before and after intervention for
the chlorhexidine and control groups by a repeated-measures model fitted to the
data. The lack of independence between counts made on the same individual
were modeled with a power model. Type of intervention (chlorhexidine or
control) and route (oral or rectal) were fitted as fixed effects.
All statistical calculations were performed in Genstat 8th edition; the param-
eters of the repeated-measures and general linear mixed models were estimated
with the restricted maximum-likelihood directive.
RESULTS
Comparison of challenge routes. Several parameters were
used to compare the oral and rectal challenge routes in exper-
iment 1 (Table 1). These included uptake, mean peak count,
mean AUC, persistence, and mean serum IgG anti-O157 LPS
responses to colonization. No statistically significant differ-
ences were demonstrated for these parameters between the
FIG. 1. Mean daily fecal E. coli O157:H7 concentrations (log10
CFU per gram) for orally (a) and rectally (b) challenged calves within
experiment 1. Surface (SF) and core (CF) fecal compartments were
calculated separately, allowing comparison on the log10 scale. Data
include all samples where separation of fecal compartments was pos-
sible within the first 14 days postchallenge. Error bars indicate the
standard errors of the means.
TABLE 1. Comparison of the two challenge routes in experiment 1 calves
Challenge
route
Uptake (no. of calves
colonized/total)
Persistence (no. of calves
shedding/total)
Mean peak count




titer)  SD (CI)
Rectal 22/24 16/22 5.8  0.6 (5.5–6.0) 2.5 1.9 (1.5–3.5)
Oral 24/30 15/20b 5.5  0.7 (5.1–5.8) 2.3 1.9 (1.3–3.3)
a CI, 95% confidence interval for the mean.
b The records for four calves were incomplete.
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two challenge routes. The daily mean levels of bacterial shed-
ding generated by the two challenge routes throughout the
14-day observation period are compared in Fig. 1a and b by
using mean fecal surface and core E. coli O157:H7 concentra-
tions. Typically, an establishment period of a few days elapsed
in which the fecal concentrations gradually increased. In the
orally challenged calves, this increase coincided with the ap-
pearance of a large surface-to-core ratio. In contrast, in the
rectally challenged calves the surface-to-core ratio was imme-
diately high, suggesting that rectal colonization occurred at
challenge. This colonization was delayed in the orally chal-
lenged calves, and the fecal E. coli O157:H7 bacteria detected
prior to this point were most likely a result of the transient
passage of the initial challenge bacteria. The mean surface-to-
core ratios beyond day 5 postchallenge were similar for both
challenge routes when calculated for grade B samples, approx-
imately log10 2. Anti-O157 LPS IgG serum titers increased
significantly in both challenge groups between the pre- and
postchallenge sampling points (P  0.001), but this increase
did not differ significantly between challenge groups (Table 1).
It was demonstrated previously (24) that although the ma-
jority of fecal E. coli O157:H7 bacteria originate at the TR, a
proportion of individuals carry low levels at other sites. These
levels typically arise in the proximal colon, though numbers of
E. coli O157:H7 bacteria in gut contents do not increase sig-
nificantly until the TR, where those originating from higher
intestinal colonization sites are obscured by much higher con-
centrations at the rectal mucosa. To confirm the TR-restricted
colonization of rectally challenged calves and provide informa-
tion on the possible degree of non-TR colonization of orally
challenged calves, postmortem sampling was performed on
calves in experiment 1 still shedding beyond day 14 postchal-
lenge. The large-intestinal-content concentrations of E. coli
O157:H7 at postmortem are shown in Fig. 2. The proximal-
colon contents were all negative for rectally challenged calves.
E. coli O157:H7 within the core samples of these calves there-
fore originated from the surface feces rather than non-TR
sites. E. coli O157:H7 concentrations were highest in the sur-
face feces, the difference being at least 10-fold and often con-
siderably higher where reliable separation of the surface and
core was achieved. For the orally challenged calves, a third (4
of 12) of the mid- and distal-colon contents contained detect-
able E. coli O157:H7 but target bacterial numbers in surface
fecal samples were always much higher and the core fecal
samples therefore contained a mixture of E. coli O157:H7 from
non-TR and TR sources.
Treatment effects in the immediate PT period. A total of 22
rectally challenged calves were colonized. Of these, 4 were left
as untreated controls, 6 were treated with polymyxin, and 12
were treated with chlorhexidine. Thirty-one orally challenged
calves were successfully colonized, and of these, 6 were un-
treated controls, 2 were treated with polymyxin, and 23 were
treated with chlorhexidine. Treatments were applied at 7 days
after challenge, and daily fecal samples were taken up to this
point and for 7 further days for enumeration of E. coli
O157:H7 bacteria. On day 7 PT, the fecal samples, if negative
by direct plating, were subjected to enrichment culture to con-
firm the absence of the challenge strain. The 11 calves in the
final group were maintained for 3 weeks after treatment to
monitor for reacquisition of the challenge strain.
A summary of the bacterial shedding by calves before and
after treatment with chlorhexidine and the same values ob-
tained for untreated controls are shown in Table 2. The most
direct means of assessing the effect of treatment is to compare
the E. coli O157:H7 concentrations in feces immediately be-
fore and 1 day after treatment application. Table 2 shows the
mean change in log10 CFU per gram for the chlorhexidine
FIG. 2. Individual E. coli O157:H7 concentrations (log10 CFU per
gram) in postmortem-derived gut contents and antemortem fecal com-
partments in experiment 1 calves. Rectally and orally challenged calves
are indicated in separate columns. Samples negative by direct plating
are in the region below the broken line labeled NEG.















Chlorhexidine 4.8a 4.3 1.5 2.8 (3.3, 2.3)b 2.1/0.7 23
None 4.6 3.8 2.9 0.9 (2.0, 0.1) 3.4/1.5 6
Rectal
Chlorhexidine 4.9 4.5 0.5 4.0 (4.7, 3.3) 1.4/0.4 12
None 4.9 4.7 4.0 0.7 (2.0, 0.6) 4.5/1.9 4
a The values shown are log10 CFU/g.
b The values in parentheses are approximate 95% confidence intervals for the mean changes in concentration.
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treatment groups together with approximate 95% confidence
intervals estimated from the general linear mixed model. A
general linear model was used to estimate significant differ-
ences between the change in the mean E. coli O157:H7 con-
centration for treatment type and challenge route. The reduc-
tion in mean bacterial concentration of the treated groups was
significantly greater than that of the untreated groups (P 
0.001). Both polymyxin and chlorhexidine produced a signifi-
cant reduction in log10 CFU per gram (mean changes of 3.4
and 3.2, respectively) relative to the untreated groups (mean
change of 0.8), but there was no evidence that one was more
effective than the other. There was evidence of a difference in
treatment effects for calves challenged by different routes. The
rectal route had a significantly greater (P 0.016) reduction in
log10 CFU per gram than the oral route (mean changes of4.0
and 2.8, respectively, for the chlorhexidine group).
Factors confounding treatment success. Within the rectally
challenged group, the treatment was highly successful, with the
majority (10/12) being cleared of any detectable fecal E. coli
O157:H7. This gives an indication of the direct effect of the
treatment at eliminating the target organism at the TR. The
success of treatment of the orally challenged group was inferior
to that of the rectally challenged group, but this difference is
only partially accounted for by E. coli O157:H7 originating
from nonrectal sites. Examination of the surface-to-core ratios
1 day after treatment (Table 3) suggests that the failure to kill
bacteria at the TR occurred in a greater proportion of the
orally challenged group (7/23) than in the rectally challenged
group (2/12). However, a Fisher’s exact test of these propor-
tions yielded a mid-P value of 0.209, indicating that the differ-
ence was insignificant. Of the 13 orally challenged calves with
101.5 CFU/g in the day 1 PT feces, 7 exhibited evidence of TR
colonization, with 5 having E. coli O157:H7 only in the surface
feces and 2 having surface-to-core ratios of 4 or greater. Eight
of the orally challenged calves had E. coli O157:H7 in the core
feces at day 1 PT, six of which had surface-to-core ratios of less
than 2, indicating likely nonrectal colonization. The fecal E.
coli O157:H7 concentrations in all but one of these were less
than 103 CFU/g.
Further analysis was performed on the bacterial counts for
several time points before and after intervention for the chlor-
hexidine and control groups with a repeated-measures model
fitted to the data. Group means and standard errors estimated
from this model are displayed in Fig. 3. There was very strong
evidence of a difference in shedding pattern over time between
the two groups (time intervention interaction, P 0.001). In
the chlorhexidine-treated groups, there was a marked decrease
in the mean number of CFU per gram after intervention.
There was also evidence of an effect of the route on the pattern
of responses (route  intervention interaction, P  0.019). In
the oral control group, the mean counts decreased fairly
steadily after the time of intervention (7 days postchallenge),
whereas the decrease appeared to be delayed in the rectal
group; however, these observations are based on small num-
bers of animals and the means have high estimated standard
errors. For animals treated with chlorhexidine, the mean de-
crease in counts was more pronounced for the rectally chal-
lenged group than for the orally challenged group.
For rectally challenged calves, an increase in shedding be-
yond day 1 PT was substantial (an increase of log10 1, with a
peak PT concentration of log10 2) in only 1 out of 12 indi-
viduals. Five of the 23 orally challenged calves had substan-
tially increased shedding beyond day 1 PT. Analysis of the day
1 PT surface-to-core ratios of these individuals (Table 3) indi-
cates examples in which recovery was likely to have originated
from TR surviving bacteria (calf 663) and non-TR colonization
FIG. 3. Analysis of the mean daily fecal E. coli O157:H7 concen-
trations (log10 CFU per gram) around the time of intervention (day 0)
for the chlorhexidine (Chlor) and control groups. A repeated-mea-
sures model was fitted to the data. Plots show the means, and error
bars indicate the standard errors estimated from the model. Rect,
rectal.
TABLE 3. Day 1 PT surface and core fecal E. coli O157:H7 levels













602 1.5 1.5 1.0
641 2.4 2.3 1.3
651 2.6 2.8 0.5
679 4.6 4.3 1.8
689 2.8 2.7 1.3
604 2.7 2.5 1.4
Likely/possible
635 3.6 1.8 53.7





a Excludes calves with no detectable E. coli O157:H7.
b ID, identification.
c SF, surface fecal concentration.
d CF, core fecal concentration.
e S/C ratio, ratio of surface to core fecal concentrations (not log10 trans-
formed).
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(calf 604), but the source of recovery was unclear for the other
three calves.
On the basis of this analysis and the colonization parameters
in Table 2, neither of the chlorhexidine-treated groups exhib-
ited marked recovery of E. coli O157:H7. In order to assess
recovery over a longer time, the final group of 11 calves was
maintained for 3 to 4 weeks PT. Although occasional samples
were enrichment culture positive for the challenge strain, there
was no evidence of recolonization once the levels became neg-
ative by direct plating (data not shown).
Rapid detection based on direct recovery of E. coli O157
from the TR. The system used to identify cattle shedding high
levels of E. coli O157 was based on the Coris BioConcept O157
Coli-Strip immunochemical detection kit. Although designed
for use with broth enrichment cultures, the test strips can
detect 104 E. coli O157 CFU/ml. Initial work suggested that
this level could be obtained by swabbing the rectal mucosa of
colonized calves. The concentrations of E. coli O157:H7 within
rectal swab suspensions were compared to the corresponding
fecal concentrations, collected up to an hour before the swab
(data not shown). A positive linear relationship between the
bacterial surface fecal levels and the swab recovery levels was
demonstrated. The detection test positively identified all sam-
ples with E. coli O157:H7 concentrations in excess of 104
CFU/ml and the majority with concentrations at this detection
limit. However, fecal concentration is used to determine the
force of E. coli O157 contamination in field studies and trans-
mission models and the detection limit of the procedure may
be unacceptably high. For example, it did not identify all calves
shedding E. coli O157:H7 above 104 CFU/g as positive. To
lower the detection limit, swab suspensions negative by the
immediate test were filtered and concentrated by centrifuga-
tion and the subsequent resuspended filtrate was retested. This
procedure yielded a positive result for samples with 102
CFU/ml or greater within the preprocessed swab suspension
(data not shown). The lowest corresponding fecal concentra-
tion of those testing positive after processing was 3.3  101
CFU/g, while the highest fecal E. coli O157:H7 concentration
of those that were negative by both tests was 3.5  103 CFU/g.
DISCUSSION
An initial objective of this study was to assess different chal-
lenge routes in establishing persistent colonization of calves
(experiment 1). In addition to the conventional oral challenge
route, a rectal challenge protocol with a methodology and
resultant colonization similar to those reported previously (28)
was used to assess the efficacy of the treatment methods in the
absence of bacteria originating from nonrectal sites. Impor-
tantly, the two challenge routes created qualitatively and quan-
titatively similar patterns of E. coli O157:H7 colonization, con-
firming the previous findings of Sheng et al. (28). Both
challenge routes resulted in similar levels of uptake, E. coli
O157:H7 shedding levels, persistence, and surface-to-core ra-
tios that indicated colonization primarily occurred at the TR.
Differences in the early stages after challenge reflect the phys-
ical differences between the two routes, as a rectal challenge
deposits bacteria immediately onto the TR mucosa. We there-
fore conclude that, beyond the initial period of establishment
of colonization, the rectal challenge method effectively repro-
duced the TR-restricted colonization pattern observed after an
oral challenge.
It was anticipated from previous data (24) that low E. coli
O157:H7 levels could originate from nonrectal regions after an
oral challenge, and this was confirmed by postmortem sam-
pling. The challenge strain was not recovered from the gut
contents of rectally challenged calves, but relatively low con-
centrations were demonstrated in the core feces, indicating
that separation of the two fecal components was rarely abso-
lute. Incomplete separation of the two components when the
surface concentration was high would therefore obscure any
low concentrations of E. coli O157:H7 present in the core feces
originating from nonrectal regions of orally challenged calves.
As an oral challenge may present the bacteria to sites such as
the Peyer’s patch, the colonization of host tissues may result in
different humoral immune responses between challenge routes
and potentially influence the clearance of the challenge bacte-
ria. Serum anti-O157 LPS antibody responses were therefore
used to compare the possible degree of exposure and re-
sponses for the two challenge routes. Although the serum
anti-O157 LPS IgG titers increased significantly in response to
colonization, the mean responses did not differ significantly
between challenge groups.
The objective of the second part of this study (experiment 2)
was the testing of two treatments applied to the TR in exper-
imentally challenged calves. Our model generates groups of
calves composed primarily of high shedders, and only those
shedding 103 CFU/g at the time of intervention were used in
the analyses. In orally challenged individuals, high numbers of
inoculated bacteria increase the potential for non-TR coloni-
zation. Thus, this experiment represents a more stringent test
of the treatment than may be expected for treatment of natu-
rally colonized cattle, in which the majority of positive individ-
uals shed very low levels (22). It is likely that high-level-shed-
ding individuals would be the most resistant to a single
treatment and are also the most important to target (18, 22).
Overall, the direct treatments were successful in reducing E.
coli O157:H7 carriage and bacterial numbers were brought
below the thresholds suggested by Matthews et al. (22) as
necessary to eliminate effective transmission of the organism.
Initially, two treatments were compared in rectally challenged
calves and shedding parameters were determined before and
after treatment. Though the difference in change between
treatment types was small, the chlorhexidine treatment was
chosen for further study. This choice was justified by the fact
that an antiseptic such as chlorhexidine does not have the
perceived risk of generating bacterial resistance associated
with an antibiotic. In addition, the lower cost of chlorhexidine
allows larger volumes to be applied, maximizing mucosal dis-
tribution, and is especially important when treating large num-
bers of large animals.
Various reasons for the failure of a treatment directly ap-
plied to the TR were anticipated. These included (i) failure of
the treatment to kill bacteria at the TR, (ii) bacteria present in
the digesta originating from nonrectal colonization sites, (iii)
recolonization of the TR by bacteria surviving the treatment at
the TR, and (iv) recolonization of the TR by bacteria originat-
ing from nonrectal sites. The difference in treatment effect
between challenge routes was significant, and detailed analysis
of the surface-to-core ratios in the PT feces of the chlorhexi-
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dine-treated calves suggests that this was partially a result of
bacteria originating from nonrectal regions in orally chal-
lenged calves (6 out of 23 calves) with the remaining difference
being due to less efficacious bacterial killing at the TR in the
orally challenged, relative to the rectally challenged, calves.
The latter difference could be accounted for by random vari-
ability, as it was statistically insignificant and postmortem sam-
pling (experiment 1) did not demonstrate any obvious differ-
ence between challenge routes in the pattern of colonization
within the rectum (data not shown). However, the possibility
that a hypothetical physiological effect, such as a stress re-
sponse or a change in gene expression following passage
through the gastrointestinal tract, reduced the bactericidal ef-
ficacy of the treatment in orally challenged calves cannot be
ruled out.
The ability to identify high shedders with a rapid field test
offers many advantages for use in conjunction with the treat-
ment methods. As the direct test can be performed on the farm
and results would be available in a very short time, it could
identify individuals shedding high levels of E. coli O157 and
facilitate the control of this microorganism within cattle in
conjunction with the direct treatment method described in this
paper.
It is beyond the scope of this paper to determine exactly how
these methods would be best applied in the field, but treatment
would have the greatest effect when applied at certain critical
control points—for example, maintenance of clean herds by
screening of introduced animals, treatment and removal of
high shedders within an infected establishment or to limit
transmission to other farms, markets, or slaughterhouses by
implementation prior to transport. Since a single treatment
was successful in the majority of individuals and reduced shed-
ding levels below the threshold suggested by Matthews et al.
(22), a large-scale experiment or field trial should be con-
ducted in which the maintenance of E. coli O157 is dependent
upon natural routes of transmission, to allow an accurate as-
sessment of the efficacy of these experimental detection and
treatment regimens. The applicability of this approach to the
control of other EHEC strains originating from cattle would
depend upon these strains also exhibiting a TR tropism. There
is no evidence from published experimental challenges that
this is the case, although the control of E. coli O157:H7 would
lead to a considerable reduction in EHEC-mediated human
disease in the majority of developed countries.
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